33: Troll of Transplantation Part 1
Febrile
00:00
Is There a Difference Between Induction and Maintenance Therapy?
For patients with normal renal function, it is recommended to preferentially use iv gan pycle of ear. The second line agents include foscarnet or sidof ofer. These agents are reserved for the second line due to their significant nephotoxicity. For those who faild to respond to gansat itervatencycleof year, a new agent, maribaver,. was recently approved by the fda in november t 21, with a much better safety profile.
Transcript
Play full episode
